Cyclic RGD-Containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting

Leonardo Manzoni, Laura Belvisi, Daniela Arosio, Monica Civera, Michael Pilkington-Miksa, Donatella Potenza, Andrea Caprini, Elena M V Araldi, Eugenia Monferini, Monica Mancino, Francesca Podesta, Carlo Scolastico

Research output: Contribution to journalArticle

Abstract

Cyclic RGD-contaning functionalized azabicycloalkane peptides were synthesized with the aim of developing high-affinity selective integrin ligands as carriers for therapeutic and diagnostic purposes. Herein we describe the synthesis and in vitro screening of these RGD derivatives, as well as the determination of their conformational properties in solution by spectro-scopic and computational methods. Docking studies with the X-ray crystal structure of the extracellular domain of integrin αvβ3were also performed to elucidate the structural binding requirements and to rationalize the biological results. One compound in particular was found to be the best αvβ3 integrin binder (IC50 = 53.7 nM) among the new functionalized RGD cyclic peptides, thus emerging as a promising candidate for co-valent bonding and selective homing of useful functional units.

Original languageEnglish
Pages (from-to)615-632
Number of pages18
JournalChemMedChem
Volume4
Issue number4
DOIs
Publication statusPublished - Apr 17 2009

Fingerprint

Integrins
Tumors
Peptides
Neoplasms
Cyclic Peptides
Computational methods
Inhibitory Concentration 50
Binders
Screening
Crystal structure
X-Rays
Ligands
Derivatives
X rays
cyclic arginine-glycine-aspartic acid peptide
Therapeutics
In Vitro Techniques
arginyl-glycyl-aspartic acid

Keywords

  • Azabicycloalkanes
  • Inhibitors
  • Integrins
  • Peptidomimetics
  • RGD motif

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry
  • Molecular Medicine

Cite this

Manzoni, L., Belvisi, L., Arosio, D., Civera, M., Pilkington-Miksa, M., Potenza, D., ... Scolastico, C. (2009). Cyclic RGD-Containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting. ChemMedChem, 4(4), 615-632. https://doi.org/10.1002/cmdc.200800422

Cyclic RGD-Containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting. / Manzoni, Leonardo; Belvisi, Laura; Arosio, Daniela; Civera, Monica; Pilkington-Miksa, Michael; Potenza, Donatella; Caprini, Andrea; Araldi, Elena M V; Monferini, Eugenia; Mancino, Monica; Podesta, Francesca; Scolastico, Carlo.

In: ChemMedChem, Vol. 4, No. 4, 17.04.2009, p. 615-632.

Research output: Contribution to journalArticle

Manzoni, L, Belvisi, L, Arosio, D, Civera, M, Pilkington-Miksa, M, Potenza, D, Caprini, A, Araldi, EMV, Monferini, E, Mancino, M, Podesta, F & Scolastico, C 2009, 'Cyclic RGD-Containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting', ChemMedChem, vol. 4, no. 4, pp. 615-632. https://doi.org/10.1002/cmdc.200800422
Manzoni L, Belvisi L, Arosio D, Civera M, Pilkington-Miksa M, Potenza D et al. Cyclic RGD-Containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting. ChemMedChem. 2009 Apr 17;4(4):615-632. https://doi.org/10.1002/cmdc.200800422
Manzoni, Leonardo ; Belvisi, Laura ; Arosio, Daniela ; Civera, Monica ; Pilkington-Miksa, Michael ; Potenza, Donatella ; Caprini, Andrea ; Araldi, Elena M V ; Monferini, Eugenia ; Mancino, Monica ; Podesta, Francesca ; Scolastico, Carlo. / Cyclic RGD-Containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting. In: ChemMedChem. 2009 ; Vol. 4, No. 4. pp. 615-632.
@article{2b83a8442e6f4bb5b944bf8ef84fcbac,
title = "Cyclic RGD-Containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting",
abstract = "Cyclic RGD-contaning functionalized azabicycloalkane peptides were synthesized with the aim of developing high-affinity selective integrin ligands as carriers for therapeutic and diagnostic purposes. Herein we describe the synthesis and in vitro screening of these RGD derivatives, as well as the determination of their conformational properties in solution by spectro-scopic and computational methods. Docking studies with the X-ray crystal structure of the extracellular domain of integrin αvβ3were also performed to elucidate the structural binding requirements and to rationalize the biological results. One compound in particular was found to be the best αvβ3 integrin binder (IC50 = 53.7 nM) among the new functionalized RGD cyclic peptides, thus emerging as a promising candidate for co-valent bonding and selective homing of useful functional units.",
keywords = "Azabicycloalkanes, Inhibitors, Integrins, Peptidomimetics, RGD motif",
author = "Leonardo Manzoni and Laura Belvisi and Daniela Arosio and Monica Civera and Michael Pilkington-Miksa and Donatella Potenza and Andrea Caprini and Araldi, {Elena M V} and Eugenia Monferini and Monica Mancino and Francesca Podesta and Carlo Scolastico",
year = "2009",
month = "4",
day = "17",
doi = "10.1002/cmdc.200800422",
language = "English",
volume = "4",
pages = "615--632",
journal = "ChemMedChem",
issn = "1860-7179",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Cyclic RGD-Containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting

AU - Manzoni, Leonardo

AU - Belvisi, Laura

AU - Arosio, Daniela

AU - Civera, Monica

AU - Pilkington-Miksa, Michael

AU - Potenza, Donatella

AU - Caprini, Andrea

AU - Araldi, Elena M V

AU - Monferini, Eugenia

AU - Mancino, Monica

AU - Podesta, Francesca

AU - Scolastico, Carlo

PY - 2009/4/17

Y1 - 2009/4/17

N2 - Cyclic RGD-contaning functionalized azabicycloalkane peptides were synthesized with the aim of developing high-affinity selective integrin ligands as carriers for therapeutic and diagnostic purposes. Herein we describe the synthesis and in vitro screening of these RGD derivatives, as well as the determination of their conformational properties in solution by spectro-scopic and computational methods. Docking studies with the X-ray crystal structure of the extracellular domain of integrin αvβ3were also performed to elucidate the structural binding requirements and to rationalize the biological results. One compound in particular was found to be the best αvβ3 integrin binder (IC50 = 53.7 nM) among the new functionalized RGD cyclic peptides, thus emerging as a promising candidate for co-valent bonding and selective homing of useful functional units.

AB - Cyclic RGD-contaning functionalized azabicycloalkane peptides were synthesized with the aim of developing high-affinity selective integrin ligands as carriers for therapeutic and diagnostic purposes. Herein we describe the synthesis and in vitro screening of these RGD derivatives, as well as the determination of their conformational properties in solution by spectro-scopic and computational methods. Docking studies with the X-ray crystal structure of the extracellular domain of integrin αvβ3were also performed to elucidate the structural binding requirements and to rationalize the biological results. One compound in particular was found to be the best αvβ3 integrin binder (IC50 = 53.7 nM) among the new functionalized RGD cyclic peptides, thus emerging as a promising candidate for co-valent bonding and selective homing of useful functional units.

KW - Azabicycloalkanes

KW - Inhibitors

KW - Integrins

KW - Peptidomimetics

KW - RGD motif

UR - http://www.scopus.com/inward/record.url?scp=65549132157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549132157&partnerID=8YFLogxK

U2 - 10.1002/cmdc.200800422

DO - 10.1002/cmdc.200800422

M3 - Article

C2 - 19212960

AN - SCOPUS:65549132157

VL - 4

SP - 615

EP - 632

JO - ChemMedChem

JF - ChemMedChem

SN - 1860-7179

IS - 4

ER -